Gene · 4838
Papers4,551
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,551
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Nrf2-mediated anti-inflammatory polarization of macrophages as therapeutic targets for osteoarthritis. | Front Immunol | 2022 | 36032081 | PubTator, text mining | PubMed |
| Regulation of Embryonic Stem Cell Self-Renewal. | Life (Basel) | 2022 | 36013330 | PubTator, text mining | PubMed |
| Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer. | Cancers (Basel) | 2022 | 36011025 | PubTator, text mining | PubMed |
| Recurrent NOMO1 Gene Deletion Is a Potential Clinical Marker in Early-Onset Colorectal Cancer and Is Involved in the Regulation of Cell Migration. | Cancers (Basel) | 2022 | 36011023 | PubTator, text mining | PubMed |
| Local Consolidative Therapy for Oligometastatic Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 36010969 | PubTator, text mining | PubMed |
| Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma. | Cells | 2022 | 36010607 | PubTator, text mining | PubMed |
| Neurons: The Interplay between Cytoskeleton, Ion Channels/Transporters and Mitochondria. | Cells | 2022 | 36010576 | PubTator, text mining | PubMed |
| Mer Tyrosine Kinase (MERTK) modulates liver fibrosis progression and hepatocellular carcinoma development. | Front Immunol | 2022 | 36003399 | PubTator, text mining | PubMed |
| SOX transcription factors direct TCF-independent WNT/β-catenin responsive transcription to govern cell fate in human pluripotent stem cells. | Cell Rep | 2022 | 36001974 | PubTator, text mining | PubMed |
| Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies. | Mol Cancer Ther | 2022 | 35999659 | PubTator, text mining | PubMed |
| Stem-cell-based human and mouse embryo models. | Curr Opin Genet Dev | 2022 | 35988317 | PubTator, text mining | PubMed |
| Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study. | Front Oncol | 2022 | 35982977 | PubTator, text mining | PubMed |
| The negative regulation of gene expression by microRNAs as key driver of inducers and repressors of cardiomyocyte differentiation. | Clin Sci (Lond) | 2022 | 35979890 | PubTator, text mining | PubMed |
| Directed differentiation of human pluripotent stem cells into diverse organ-specific mesenchyme of the digestive and respiratory systems. | Nat Protoc | 2022 | 35978039 | PubTator, text mining | PubMed |
| Loss of FOXA2 induces ER stress and hepatic steatosis and alters developmental gene expression in human iPSC-derived hepatocytes. | Cell Death Dis | 2022 | 35973994 | PubTator, text mining | PubMed |
| SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells. | Theranostics | 2022 | 35966598 | PubTator, text mining | PubMed |
| The trophectoderm acts as a niche for the inner cell mass through C/EBPα-regulated IL-6 signaling. | Stem Cell Reports | 2022 | 35961310 | PubTator, text mining | PubMed |
| A brief overview about the adipokine: Isthmin-1. | Front Cardiovasc Med | 2022 | 35958402 | PubTator, text mining | PubMed |
| Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway. | Front Oncol | 2022 | 35957886 | PubTator, text mining | PubMed |
| Repair of Retinal Degeneration by Human Amniotic Epithelial Stem Cell-Derived Photoreceptor-like Cells. | Int J Mol Sci | 2022 | 35955866 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4838/papers?page=38